Effect of Trisindolina 1 on CD44 and CD123 in Cancer Stem Cell using in-silico method Putu Indrayuma Kamajaya, Edwin Setiawan, Awik Puji Dyah Nurhayati
Institut Teknologi Sepuluh Nopember
Abstract
Cancer stem cells (CSC) are a type of cancer cell that has similarities to stem cells. The general method used in cancer treatment usually involve administration of chemotherapy compounds such as doxorubicin, but due to the severity of the side effects of chemotherapy, it is necessary to have alternative compounds that have high cytotoxic activity with low side effects. This study was conducted to examine the anti-cancer potential of Trisindolina 1 with structure 5^-nitro-[3,3^:3^,3^-terindoline]-2^-ona in CSC by targeting biomarkers such as CD44 and CD123. The method used is molecular docking with an in-silico approach using PyRx with Trisindolina 1 against CD44 and CD123 biomarkers with doxorubicin as the positive control . The docking results showed that the Trisindolina 1 has Gibbs free energy value of -8.3 Kcal/mol compared to doxorubicin -8.4 Kcal/mol on CD44 and -9.5 Kcal/mol compared to doxorubicin -7.7 Kcal/mol on CD123. This result indicate that Trisindolina 1 had the potential as an inhibitor of the HER2 signalling pathway in CD44 and JAK2-STAT5 signalling pathway in CD123 thus stimulate apoptosis through intrinsic pathway in CSC.
Keywords: Biomarker, Cancer Stem Cell and Trisindoline 1
